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Objective. Ectopic lymphoid structures (ELS) develop at sites of infection, autoimmunity, and cancer. In patients 
with Sjögren’s syndrome (SS), ELS support autoreactive B cell activation and lymphomagenesis. Interleukin- 27 (IL- 
27) is a key regulator of adaptive immunity and limits Th17 cell–driven pathology. We undertook this study to elucidate 
the role of IL- 27 in ELS formation and function in autoimmunity using a murine model of sialadenitis and in patients 
with SS.
Methods. ELS formation was induced in wild- type and Il27ra−/− mice via salivary gland (SG) cannulation of a 
replication- deficient adenovirus in the presence or absence of IL- 17A neutralization. In SG biopsy samples, IL- 27–
producing cells were identified by multicolor immunofluorescence microscopy. Lesional and circulating IL- 27 levels 
were determined by gene expression and enzyme- linked immunosorbent assay. The in vitro effect of IL- 27 on T cells 
was assessed using fluorescence- activated cell sorting and cytokine release.
Results. In experimental sialadenitis, Il27ra−/− mice had larger and more hyperactive ELS (focus score; P < 0.001), 
increased autoimmunity, and an expanded Th17 response (P < 0.001), compared to wild- type mice. IL- 17 blockade 
in Il27ra−/− mice suppressed the aberrant ELS response (B and T cell reduction against control; P < 0.01). SS patients 
displayed increased circulating IL- 27 levels (P < 0.01), and in SG biopsy samples, IL- 27 was expressed by DC- 
LAMP+ dendritic cells in association with CD3+ T cells. Remarkably, in SS T cells (but not in T cells from patients with 
rheumatoid arthritis or healthy controls), IL- 27–mediated suppression of IL- 17 secretion was severely impaired and 
associated with an aberrant interferon- γ release upon IL- 27 stimulation.
Conclusion. Our data indicate that the physiologic ability of IL- 27 to limit the magnitude and function of ELS 
through control of Th17 cell expansion is severely impaired in SS patients, highlighting a defective immunoregulatory 
checkpoint in this condition.
INTRODUCTION
Infection, autoimmunity, and cancer can induce a state of 
inflammation in nonlymphoid tissues that can lead to the antigen- 
driven formation of lymphoid structures at these ectopic sites (1). 
This process, ectopic lymphoneogenesis, culminates with the 
formation of ectopic lymphoid structures (ELS). ELS are charac-
terized by B cell and T cell infiltrates that are often organized into 
germinal center (GC)–like structures with segregated B cell and 
T cell areas, follicular dendritic cell (FDC) networks, and other 
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markers of GC activity (1,2). Whereas in cancer and infection ELS 
can often have a protective role, in autoimmunity, ectopic lym-
phoneogenesis is associated with more aggressive inflammation 
and worse prognosis (1,3) due to the ability of ELS to provide 
a local niche for the survival of autoreactive T cells, B cells, and 
plasma cells. In Sjögren’s syndrome (SS), an autoimmune exocrin-
opathy with prevalent salivary gland (SG) involvement (4,5), ELS 
form in 20–40% of patients (6) and are associated with higher 
systemic disease severity (7) and the development of parotid B 
cell mucosa- associated lymphoid tissue type lymphomas, albeit 
with some controversy (8–12).
Interleukin- 27 (IL- 27) is a heterodimeric cytokine composed 
of IL- 27p28 and Epstein-Barr virus–induced gene 3 (EBI-3) sub-
units, the latter being shared with IL- 35. IL- 27 signals through a 
receptor complex comprising a unique IL- 27 receptor α (IL- 27Rα) 
chain, and the common IL- 6 family signaling receptor, gp130 
(13,14). In infection, IL- 27 regulates both innate and adaptive 
immunity (14–17). IL- 27 was initially described as a proinflamma-
tory cytokine that promotes Th1 cell differentiation and cytotoxic 
CD8+ T cell responses through regulation of T- bet (18,19). Sub-
sequently, IL- 27 was shown to modulate T cell hyperactivation 
(16,20), regulation of IL- 2 (21,22), IL- 10 (23), and IL- 22 (24) pro-
duction in CD4+ T cells (25), induction of B cell class- switching 
(26), and regulation of Th17 and Treg cell differentiation (27–31).
To determine the role of IL- 27 in modulating the magnitude 
and functionality of ELS, we used a murine model of SG inflam-
mation featuring ELS formation and breach of self- tolerance 
(32), focusing on the ability of IL- 27 to regulate the expansion 
of IL- 17A–producing T cells. To extend the observations from 
our model to autoimmunity, we also characterized the systemic 
and SG presence of IL- 27 in SS patients and measured the ability 
of SS- derived peripheral blood CD4+ T cells to respond to IL- 27 
stimulation in vitro.
MATERIALS AND METHODS
Human samples. Experiments using samples from human 
subjects were performed on blood and SG tissue collected from 
54 consecutive SS patients and 45 nonspecific chronic sialadeni-
tis patients visiting a specialist rheumatology/oral medicine clinic 
at Barts Health NHS Trust (see Supplementary Table 1, on the 
Arthritis & Rheumatology website at http://onlin elibr ary.wiley.com/
doi/10.1002/art.41289/ abstract). All procedures were approved 
by the local ethics committee (LREC 05/Q0702/1 and LREC 17/
WS/0172) and performed after obtaining informed written con-
sent. For the histologic classification of SG tissue, 5- μm paraffin- 
embedded sections were stained with hematoxylin and eosin 
(H&E) to determine the infiltrate focus score (number of cellular 
aggregates with >50 cells per 4 mm2 of gland tissue). The level 
and quality of SG immune cell infiltration was characterized by 
immunohistochemistry, in order to assess the degree of T cell 
(CD3), B cell (CD20), and plasma cell (CD138) infiltration and the 
presence of FDC networks (CD21) (Supplementary Figure 1A, 
http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ abstract).
Patients were classified as ELS+ if the SG biopsy sam-
ple showed ≥1 infiltrate with clear B cell/T cell segregation and 
positive CD21 staining (33). Demographic data for SS patients 
with characterized histology is provided in Supplementary Table 
2 (http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ abstract). 
The effects of IL- 27 stimulation were determined in vitro by treat-
ing peripheral blood mononuclear cells (PBMCs) from a subcohort 
of SS patients, rheumatoid arthritis (RA) patients, and age- and 
sex- matched healthy donors with increasing doses of recombi-
nant IL- 27. Demographic data for this subcohort is provided in 
Supplementary Table 1.
Animals and treatment. All procedures were performed 
with ethical approval (PPL 70/8259 and P7867DADD) from the 
Home Office and local animal welfare committees. Il27ra−/− mice 
have been described previously (34). Female Il27ra−/− mice and 
wild- type (WT) control mice on the C57BL/6 background were 
bred and maintained under pathogen- free conditions at Cardiff 
University, or acquired from Charles River and maintained in the 
Biomedical Service Unit at Queen Mary University of London. 
For adenovirus cannulation (32) of the SGs, mice were anes-
thetized by administration of ketamine (60 mg/kg) and xylazine 
(12 mg/kg) intraperitoneally. Analgesia was provided as 0.1 mg/
kg buprenorphine hydrochloride via subcutaneous injection. The 
submandibular gland was cannulated through the excretory duct 
using heat- drawn glass gas chromatography tubing (0.1-mm 
internal diameter; Sigma- Aldrich). Approximately 20 μl adenovi-
rus solution, equivalent to ≥1010 plaque- forming units of reporter- 
encoding adenovirus, was injected into the submandibular gland 
using an attached Hamilton syringe (Sigma- Aldrich). For IL- 17A 
blockade, mouse anti- mouse IL- 17A antibody (clone 17F3; BioX-
ell) or matched isotype control (clone MOPC21; BioXell) was 
administered intraperitoneally at 500 μg per mouse every 3 days, 
starting from the day before virus infection.
Gene expression. Total RNA was extracted from tissue 
using an RNeasy Mini kit (Qiagen) and from murine CD11b+ 
cells using an Arcturus PicoPure RNA kit (ThermoFisher). Com-
plementary DNA (cDNA) was synthesized with a ThermoScript 
System (Invitrogen). For whole tissue analysis, samples were run 
in duplicate at 5 ng cDNA/well, detected using an ABI PRISM 
7900HT instrument, and results were analyzed using an ABI 
PRISM Sequence Detection System, version 2.1. For isolated 
CD11b+ cells, cDNA samples were run at 5 ng cDNA/well using 
Applied Biosystems TaqMan probes on a Biomark HD instrument 
and analyzed with real- time polymerase chain reaction (PCR) 
analysis software (both from Fluidigm). Primers and probes for 
quantitative TaqMan real- time PCR were obtained from Applied 
Biosystems (Supplementary Table 3, http://onlin elibr ary.wiley.
com/doi/10.1002/art.41289/ abstract). Relative quantification 
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was assessed by the comparative threshold cycle method using 
18S (human samples and murine myeloid cells) or Hprt genes 
(murine tissue samples) as housekeeping genes. Relative quan-
titation was calibrated using a selected lymph node cDNA for 
murine samples, and a patient with sicca symptoms was select ed 
for human experiments.
Isolation of leukocytes from tissue and blood. Murine 
SGs were digested in medium containing collagenase D (Roche) 
and DNase I (Sigma- Aldrich). CD11b+ cells were obtained with a 
positive magnetic selection kit (EasySep). PBMCs were isolated 
from human blood by density gradient (Lymphoprep; StemCell 
Technologies). For pSTAT staining and cell surface IL- 27Rα detec-
tion, cells were used directly after isolation. IL- 27 stimulation 
of human PBMCs is described in the Supplementary Methods 
(http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ abstract).
Flow cytometry. For cytokine detection, single- cell sus-
pensions were first stimulated for 4 hours at 37°C in the presence 
of Leukocyte Activation Cocktail (BD Biosciences). Cells were 
then incubated with a live/dead exclusion dye (Aqua Zombie; 
BioLegend) followed by Fc receptor blocking solution (TruStain; 
BioLegend) and surface antibodies mix (Supplementary Table 4, 
http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ abstract). 
Cells were washed, fixed, and permeabilized (eBioscience FoxP3 
fixation/permeabilization kit; ThermoFisher) and stained with intra-
cellular antibodies mix (Supplementary Table 4). Cells were then 
washed and acquired. When an absolute count was required, 
Invitrogen CountBright counting beads (ThermoFisher) were used. 
For detection of pSTAT1 and pSTAT3, PBMCs were incubated 
in medium- containing surface antibodies (Supplementary Table 2, 
http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ abstract) in 
the presence or absence of 40 ng/ml human IL- 27 for 15 minutes 
at 37°C. Cells were then fixed in paraformaldehyde, permeabi-
lized in 90% methanol, and incubated with pSTAT1- and pSTAT3- 
specific antibodies. Events were acquired on an LSR Fortessa 
cytometer (BD Biosciences) within 24 hours, and analysis was 
performed using FlowJo X. For human experiments, events were 
gated on viable cells, while murine samples were gated for via-
ble/CD45+ cells. Where relevant, a dump channel was used to 
exclude nonrelevant populations (human panels V510/20, murine 
panels R780/60).
Histology and immunofluorescence. Detailed methods 
for slide preparation from frozen and paraffin- embedded tissue blocks 
are provided in the Supplementary Methods (http://onlin elibr ary. 
wiley.com/doi/10.1002/art.41289/ abstract). See Supplementary 
Table 4 for a list of fluorochrome- conjugated primary antibodies 
used for immunofluorescence staining.
Three- micrometer sections from human formalin- fixed 
paraffin-embedded tonsillectomies and minor SGs from SS 
patients underwent deparaffinization and target retrieval and 
were stained with primary antibodies (Supplementary Table 4) 
and detected using fluorescent secondary antibodies. Nuclei 
were counterstained with DAPI, and slides were mounted with 
ProLong Gold medium. Digital image analysis was performed 
using Fiji and Qupath (35,36).
Protein detection in sera and supernatants. IL- 27 lev-
els in the undiluted sera of patients with SS and those with sicca 
symptoms were quantified by enzyme- linked immunosorbent 
assay (ELISA) (no. DY2526) according to the instructions of 
the manufacturer (R&D Systems). Interferon- γ (IFNγ) in cell culture 
supernatants was quantified using a human IFNγ ELISA kit (no. 
430104; BioLegend). For this, supernatants were diluted 1:5,000 
or 1:10,000, and biologic duplicates were pooled and quantified in 
technical duplicates. For the detection of IL- 17A, IL- 17F, IL- 21, and 
IL- 22 in undiluted cell culture supernatants, a customized multiplex 
liquid phase immunoassay (LegendPlex) was used according to 
the instructions of the manufacturer (BioLegend).
Detection of antiadenovirus and antinuclear anti-
bodies (ANAs) in serum. Ninety- six half- well ELISA plates 
(Corning) were coated overnight at 4°C with either 5 μg/ml ade-
novirus solution (anti- adenovirus ELISA) or 10 μg/ml nuclear 
extract obtained from a HEp- 2 cell line (ANA ELISA). For the ANA 
ELISA, the purity of the extract was assessed by Western blot-
ting with antibodies against laminin α and tubulin (Supplementary 
Methods and Supplementary Figure 2, http://onlin elibr ary.wiley.
com/doi/10.1002/art.41289/ abstract). For the antiadenovirus 
antibody ELISA, a standard curve was created using serial dilu-
tions of pooled sera from adenovirus- cannulated mice culled at 
19 days post- cannulation. For the ANA ELISA, a standard curve 
was created using serial dilutions of pooled sera from MRL- lpr/
lpr mice that spontaneously develop a wide range of autoanti-
bodies. Murine sera were diluted to working concentration in 1% 
bovine serum albumin and 0.05% Tween 20 in phosphate buff-
ered saline and plated in technical duplicates.
Class- specific antibodies were detected by adding biotinylated 
anti- mouse IgG1 or IgG2 detection antibodies followed by horse-
radish peroxidase–conjugated streptavidin (both from BioLegend). 
Antibodies were detected by incubation with tetramethylbenzidine 
substrate (BioLegend), and absorbance was read at 450 nm. 
Standard curves were calculated using a 4- parameter logistic 
regression, and the concentrations of unknown samples were cal-
culated and expressed as arbitrary units.
Statistical analysis. Differences in quantitative variables 
between 2 groups were analyzed by Mann- Whitney 2- tailed U 
test. For multiple comparisons, Kruskal- Wallis test with Dunn’s 
post hoc correction was used. In experiments with matched 
observations, Friedman’s test with Dunn’s correction was used. 
All statistical analyses were performed using GraphPad Prism, 
version 7.04. P values less than 0.05 were considered significant.
LUCCHESI ET AL 1562       |
RESULTS
Stepwise IL- 27 induction in murine SG- infiltrating 
immune cells following viral infection. To investigate 
the control of SG inflammation by IL- 27, we utilized a well- 
established model of inducible sialadenitis, characterized by an 
early activation of the resident stroma and innate immune cells, 
followed by accumulation of T cells and B cells, and the formation 
of ELS with functional GCs (32,37,38) (Supplementary Figure 3A, 
http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ abstract).
In whole- gland gene expression profiling, Il27p28 messenger 
RNA (mRNA) was strongly induced by adenovirus infection, peak-
ing as early as 5 days post- cannulation followed by a progressive 
decrease, but with a sustained expression throughout the course 
of the infection (Figure  1A). Consistent with previous evidence 
describing antigen- presenting cells as a prominent source of IL- 
27 (39), Il27p28 expression was strongly up- regulated in infiltrating 
CD11b+ myeloid cells at 5 days post- cannulation, but decreased 
to baseline thereafter (Figure 1B). Flow cytometry of digested SGs 
confirmed this observation (Figure 1C).
Interestingly, in uninfected SGs, expression of IL-27p28 
was mostly confined to CD45− epithelial cell adhesion mole-
cule–positive (EpCAM+) cells (Figure 1D), while CD45+ hemato-
poietic cells were the main source in adenovirus- infected glands 
(Figure  1E). Specifically, by 12 days post- cannulation, CD4+ 
and CD8+ T cells, natural killer cells, and B cells were the main 
IL- 27–producing CD45+ subsets in the SGs, both in terms of 
absolute numbers and as a percentage of IL- 27–producing leu-
kocytes (Figure 1F and Supplementary Figure 3D, http://onlin e 
libr ary.wiley.com/doi/10.1002/art.41289/ abstract). These subsets 
Figure 1. Interleukin- 27 (IL- 27) is produced in the murine salivary gland (SG) at the steady state and upon viral challenge. A, Expression of 
IL- 27 subunits and the IL- 27 receptor (Il27p28, Ebi3, and Il27ra, respectively), determined by real- time quantitative polymerase chain reaction in 
whole SG tissue at the steady state (n = 14) and at 5 days (n = 23), 12 days (n = 25), and 19 days (n = 19) post- cannulation (dpc). B, Il27p28, 
Ebi3, and Il27ra expression in sorted CD11b+ myeloid cells at 5 days (n = 12), 12 days (n = 8), and 19 days (n = 8) post- cannulation. C, Absolute 
cell counts of IL- 27p28–producing CD11b+ cells based on flow cytometry of enzymatically digested infected SGs (n = 10) and uninfected SGs 
(n = 6) at 5 days post- cannulation. D, Representative plots showing gating strategy for IL- 27p28–producing viable single cells in the CD45− and 
CD45+ populations (left) and overlay histograms of the IL- 27p28–producing cells in untreated and adenovirus (AdV)– challenged mice (right). 
E, Absolute cell counts of IL- 27p28–producing cells based on flow cytometry of enzymatically digested infected SGs (n = 6) and uninfected 
SGs (n = 10) at 12 days post- cannulation. F, Absolute count of the main IL- 27p28–producing CD45+ subpopulations present in inflamed SGs. 
Symbols represent individual mice; bars show the mean ± SEM. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.0001 versus controls, by 
Kruskal- Wallis multiple comparison test in A and B and by Mann- Whitney U test in C, E, and F. RQ = relative quantification; NS = not significant; 
Epcam = epithelial cell adhesion molecule; NK = natural killer.
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also showed an increase in the mean fluorescence intensity of IL- 
27 staining in fluorescence-activated cell sorting (Supplementary 
Figure 3C), suggesting an increase not only in the number of IL- 
27–producing cells but also an overall increase in the levels of IL- 
27 produced. A pie chart representing the individual contributions 
of the various immune cells subsets is presented in Supplemen-
tary Figure 3D. A decrease in the number of IL- 27+ epithelial cells 
appears related to the abundant cell death among EpCAM+ SG 
epithelial cells upon infection (Supplementary Figure 3E). Overall, 
these data demonstrate that upon viral infection in the SGs, differ-
ent cell types become able to produce IL- 27 at diverse stages of 
the inflammatory and lymphoneogenic process.
Up- regulation of IL- 27 in SGs of SS patients with 
ELS, mainly produced by DC- LAMP+ dendritic cells in 
T cell–rich areas. In our previous work, reduced levels of IL- 
27 mRNA in the inflamed joints of RA patients were associated 
with a higher incidence of ELS, suggesting that an intrinsic defect 
in IL- 27 may favor ELS formation in the inflamed joints (40). How-
ever, when we analyzed IL- 27–related gene transcripts in the SGs 
of SS patients, we observed a significantly higher expression of 
IL27p28, EBI3, and IL27Rα mRNA, compared to patients with 
nonspecific chronic sialadenitis (sicca) who develop exocrine dys-
function without the autoimmune component typical of SS (Fig-
ure 2A). Unexpectedly, when we separated SS patients into ELS+ 
and ELS− groups based on SG immunohistology (Supplementary 
Figure 1A, http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ 
abstract), ELS+ patients displayed higher expression levels of 
IL27, EBI3, and IL27RA, compared to ELS− patients (Figure 2B), 
while there was no difference between ELS− SS patients and 
ELS− sicca patients. This was also confirmed by the positive cor-
relation of the percentage of infiltrating B cells, T cells, and plasma 
cells with gene expression for the IL- 27 signaling cassette (Fig-
ure 2C). Conversely, although we observed higher serum  levels of 
Figure 2. DC- LAMP+ dendritic cells are the main producer of IL-27 in human tonsil and SG ectopic lymphoid structures (ELS). A and B, 
Real- time quantitative polymerase chain reaction gene expression for IL27, EBI3, and IL27RA in patients with Sjögren’s syndrome (SS) (n = 29) 
and patients with nonspecific chronic sialadenitis (sicca) (n = 20) (A) and in ELS+ SS patients (n = 14) and ELS− SS patients (n = 15) (B) on 
RNA extracted from SG biopsy samples. C, Spearman’s correlation table showing rho values between IL27, EBI3, and IL27RA gene expression 
and the percentage of cells positive for CD20, CD3, and CD138 over total cells detected in minor SG histologic sections from SS and sicca 
patients. D, Representative immunofluorescence staining of paraffin- embedded sections from human tonsils and SGs from ELS+ SS patients. 
Top row shows staining for CD3+ T cells (green), IL- 27p28 (red), and CD20+ B cells (white; bottom row shows staining for  DC-LAMP+ dendritic 
cells (green),  IL- 27p28 (red), and CD68+ macrophages (white). Nuclei counterstained with DAPI (blue). Split channel and merge panels show 
higher-magnification views of the boxed areas. In A and B, symbols represent individual patients; bars show the mean ± SEM. * = P < 0.05; 
** = P < 0.01; *** = P < 0.001; **** = P < 0.0001, by Mann- Whitney U test in A and by Kruskal- Wallis test in B. See Figure 1 for other definitions.
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IL-27 in SS patients compared to those with sicca, there was no 
difference when comparing the ELS+ and ELS− subsets (Supple-
mentary Figures 1B and C).
Similar to findings in mouse SGs following viral infection, mul-
ticolor immunofluorescence identified many IL- 27p28–producing 
cells with a dendritic morphology localized in the T cell–rich areas 
surrounding B cell follicles and in close contact with CD3+ T cells 
in both the inflamed tonsils and ELS+ SGs of SS patients (Fig-
ure 2D). Most of the IL- 27p28–producing cells in ELS+ SGs and 
in tonsils were in fact DC- LAMP+ dendritic cells (Figure 2D) and 
not CD68+ macrophages, CD3+ T cells, or CD20+ B cells, con-
firming that in both mouse and human inflamed SG tissues, IL- 27 
is mainly produced by cells of myeloid lineage. Importantly, we 
were able to identify by flow cytometry IL- 27Rα–positive mono-
nuclear cells in the minor SG infiltrate in SS patients. Interestingly, 
among the cells positive for IL- 27Rα in the gland, the majority 
were CD4+ T cells (Supplementary Figure 1F, http://onlin elibr ary.
wiley.com/doi/10.1002/art.41289/ abstract), which confirms that 
the inflammatory microenvironment of SS SGs harbors both IL- 
27–producing and IL- 27–responsive cells.
Impaired IL- 27 signaling in Il27ra−/− mice promotes 
aberrant ELS formation and activity during viral- induced 
sialadenitis. We next investigated the incidence, quantita-
tive spatial composition, and function of ELS forming in SGs in 
Il27ra−/− mice versus WT mice following adenovirus infection. ELS 
Figure 3. Inflamed SGs in Il27ra−/− mice show increased ectopic lymphoid structure (ELS) formation and germinal cell markers. A, Representative 
immunofluorescence for B220+ B cells and CD3+ T cells in SGs from adenovirus- treated wild- type (WT) mice (n = 8 glands) and Il27ra−/− mice 
(n = 10 glands) at 19 days post- cannulation. B, Average focus score (FS) of 3 cutting levels (60 μm apart) per gland (WT n = 8, Il27ra−/− n = 10), area 
fraction of SG staining positive for B cells and T cells (WT n = 8, Il27ra−/− n = 10), and the ratio between B cell and T cell areas (WT n = 6, Il27ra−/− 
n = 9). C, Gene expression analysis of SGs from uninfected controls (n = 8) and adenovirus- infected WT mice and Il27ra−/− mice at 12 days post- 
cannulation (WT n = 8, Il27ra−/− n = 18) and 19 days post- cannulation (WT n = 18, Il27ra−/− n = 10). D, Representative immunofluorescence and 
quantification of B cell and CD21+ follicular dendritic cell (FDC) aggregates per gland (WT n = 7, Il27ra−/− n = 10). E, Flow cytometry quantification 
of GL- 7+ cells over total B220+ B cells in SGs from WT mice (n = 10) and Il27ra−/− mice (n = 10) at 19 days post- cannulation. F, Gene expression 
analysis for Aicda in SGs (numbers of mice per group as in C). G, Antinuclear antigen–specific serum antibody titer at 19 days post- cannulation, 
determined by enzyme- linked immunosorbent assay (ELISA) (WT n = 17, Il27ra−/− n = 16). H, Antiadenovirus- specific serum titers at 19 days post- 
cannulation, determined by ELISA (WT n = 17, Il27ra−/− n = 16). In B–F, symbols represent individual SGs, and in G and H, symbols represent 
individual mice; bars show the mean ± SEM. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.0001, by Mann- Whitney U test. See Figure 1 for 
other definitions. Color figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/doi/10.1002/art.41289/abstract.
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were more abundant and larger in Il27ra−/− mice (Figures 3A and 
B and Supplementary Figure 4, http://onlin elibr ary.wiley.com/
doi/10.1002/art.41289/ abstract). Consistent with these findings, 
higher transcripts of Ltb and lymphoid chemokines Cxcl13 and 
Ccl19 and their receptors Cxcr5 and Ccr7, which are critical in 
the development of ELS, were observed in Il27ra−/− mice than in 
WT mice, both before (12 days post- cannulation) and concomitant 
with (19 days post- cannulation) the formation of ELS (Figure 3C). 
Notably, no differences were observed between uninfected SGs 
from WT mice and those from Il27ra−/− mice in histology (Supple-
mentary Figure 4) or ELS- related gene expression (Supplementary 
Figure 5A, http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ 
abstract).
The proportion of ELS displaying CD21+ FDC networks 
was significantly higher in cannulated Il27ra−/− mice compared to 
controls (Figure 3D). An exaggerated ectopic GC response was 
also confirmed by a higher prevalence of GL7+ GC B cells in the 
SGs of Il27ra−/− mice (Figure 3E) and higher expression levels of 
activation- induced cytidine deaminase (AID; Aicda), the enzyme 
responsible for somatic hypermutation and class- switch recom-
bination (Figure  3F). Previous studies showed that IL- 27 drives 
IgG2a but not IgG1 Ig class- switching in B cells (26). Accordingly, 
Figure 4. Exaggerated ectopic lymphoid structure (ELS) development in Il27ra−/− mice is mediated by IL- 17A. A, Representative dot plots of CD4+ 
T cells from adenovirus- treated wild- type (WT) and Il27ra−/− mice. B, Quantification of interferon- γ–positive (IFNγ+) cells (WT n = 41, Il27ra−/− n = 18), 
IL- 17+ cells (WT n = 32, Il27ra−/− n = 18), and FoxP3+/CD25+ cells (WT n = 10, Il27ra−/− n = 10) as a percentage of CD4+ T cells in Il27ra−/− and WT 
mice. C, Real- time quantitative polymerase chain reaction for expression of Ifng (WT n = 16, Il27ra−/− n = 18), Il17a (WT n = 16, Il27ra−/− n = 18), and 
Foxp3 (WT n = 8, Il27ra−/− n = 8) in SG tissue from adenovirus- infected WT and Il27ra−/− mice. Data are shown as box plots. Each box represents the 
25th to 75th percentiles. Lines inside the boxes represent the median. Lines outside the boxes represent the minimum and maximum values. Symbols 
represent individual mice. D, Dosing regimen for IL- 17A depletion in vivo. E, Representative immunofluorescence for T cells and B cells. F, Area fraction 
of B cell and T cell infiltrates and their ratio in the glands of Il27ra−/− anti–IL- 17A–treated mice (n = 11) and Ig- treated mice (n = 18). G, Quantification of 
CD21+ B cell aggregates per gland (Ig n = 11, anti–IL- 17A n = 10). H, Gene expression in SGs from anti–IL- 17A–treated mice and Ig- treated mice at 
12 days post- cannulation (Ig n = 18, anti–IL- 17A n = 7) and 19 days post- cannulation (Ig n = 20, anti–IL- 17A n = 11). I, IFNγ+ cells (Ig n = 10, anti–IL- 
17A n = 10), IL- 17+ cells (Ig n = 10, anti–IL- 17A n = 9), and FoxP3+/CD25+ cells (Ig n = 10, anti–IL- 17A n = 10) as a percentage of CD4+ T cells in 
anti–IL- 17A–treated and Ig- treated Il27ra−/− animals at 12 days post- cannulation. In B, F, G, H, and I, symbols represent individual SGs; bars show the 
mean ± SEM. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.0001, by Mann- Whitney U test. FDC = follicular dendritic cell (see Figure 1 for other 
definitions). Color figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/doi/10.1002/art.41289/abstract.
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we detected higher levels of IgG1 but not IgG2a ANAs and anti-
adenovirus antibodies in the sera of Il27ra−/− mice compared to 
WT mice (Figures 3G and H). Overall, in our model, IL- 27 regulates 
the magnitude of the local ectopic GC response, and ELS develop 
unopposed in the absence of a regulatory IL- 27 response.
Uncontrolled expansion of IL- 17–producing CD4+ 
cells drives aberrant ectopic GCs in the SGs of Il27ra−/− 
mice, which are restored upon IL- 17A blockade. Given the 
importance of IL- 27 in shaping T cell responses, we speculated 
that the exaggerated formation and hyperactivity of ELS observed 
in Il27ra−/−mice may be due to an early, dysregulated, and imbal-
anced CD4+ T cell activation in the SGs.
Intracellular flow cytometry on digested SGs at the peak of T 
cell infiltration (12 days post- cannulation) (Figure 4A) confirmed a 
striking enrichment in the percentage of IL- 17A–producing CD4+ 
T cells in Il27ra−/− mice compared to WT mice (Figures 4A and B). 
This was accompanied by a significant decrease in the percentage 
of IFNγ- producing CD4+ cells (Figures 4A and B). Gene expression 
analysis showed parallel modulation of Ifng and Il17a mRNA in the 
infected SGs (Figure 4C). Consistent with the findings of previous 
studies that highlighted a role for IL- 27 in suppressing inducible 
Treg cells (28,31), we observed an increased number of FoxP3+/
CD25+ Treg cells and elevated gene expression of the transcrip-
tion factor FoxP3 in cannulated SGs from Il27ra−/− mice compared 
to WT mice (Figures 4A–C). The heightened expression of genes 
involved in both Treg cell differentiation and chemotaxis in the SGs 
of Il27ra−/− mice versus WT mice (Supplementary Figure 5B, http://
onlin elibr ary.wiley.com/doi/10.1002/art.41289/ abstract) suggests 
that both phenomena contribute to the increased number of infil-
trating FoxP3+/CD25+ Treg cells observed.
To test whether a functional link might exist between the local 
production of IL- 17A and the expansion of ELS in the SGs of 
Il27ra−/− mice, we administered a neutralizing anti–IL- 17A antibody to 
Il27ra−/− mice (Figure 4D). In IL- 17A–neutralized mice, we observed 
smaller and less organized inflammatory foci in the SGs (Figure 4E). 
A significant reduction in the T cell and B cell compartments was 
observed following treatment with the anti–IL- 17A antibody (Fig-
ures 4E and F), restoring the B cell:T cell ratio close to levels observed 
in WT animals (Figures 3B and 4F), indicating that IL- 27 control of 
ELS composition is mediated through suppression of the Th17/IL- 17 
response. These changes in ELS following IL- 17 neutralization were 
paralleled by a reduction in the expression of genes required for ELS 
formation (Figure 4H). Anti–IL- 17A–treated animals also displayed a 
notable reduction in GC function, as shown by a reduction in FDC 
networks and Aicda expression (Figures 4G and H).
Interestingly, we noticed a decrease in the percentage of 
IFNγ- and IL- 22–producing cells (Supplementary Figures 6A and B, 
http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ abstract) in CD4+ 
T cell subsets present in the SGs of IL- 17A–depleted, adenovirus- 
infected Il27ra−/− mice, while Treg cell and IL- 17A–producing 
T cell percentages were unchanged (Figure 4I). Anti–IL- 17A treat-
ment did not affect the virus- specific serum IgG1:IgG2a ratio 
(Supplementary Figure 6C). Taken together, these observations 
suggest that in our model of viral- induced ELS formation, IL- 27 
limits the magnitude of SG- infiltrating Th17 cells, and that in the 
absence of IL- 27, IL- 17A is responsible for the expansion of ELS 
and ectopic GC hyperactivation.
Characterization of CD4+ T cells by dysfunctional 
IL- 17 and IFNγ responses to IL- 27 in SS. To reconcile our 
data showing IL- 27–driven inhibition of ELS formation with the 
apparently contradictory elevation of IL- 27 in the SGs of ELS+ SS 
patients, we investigated whether CD4+ T cells from SS patients 
displayed an aberrant response to IL- 27. We first confirmed that 
there was no difference between SS patients and healthy donors 
in surface IL- 27Rα expression on CD4+ T cells, CD8+ T cells, or 
B cells (Figure 5A). Although surface expression of IL- 27Rα was 
slightly higher in Th17 cells compared to Th1 cells, we did not 
see major differences in IL- 27Rα expression on T helper cell sub-
sets between SS patients and healthy donors (Supplementary 
Figure 1E, http://onlin elibr ary.wiley.com/doi/10.1002/art.41289/ 
abstract). Similarly, we did not observe any significant difference 
in the levels of STAT1/3 phosphorylation in the total leukocyte 
population nor in individual subsets when we stimulated fresh 
PBMCs with IL- 27s in samples from SS patients and healthy 
donors (Figures 5B and C). We also observed that in our cohort, 
serum levels of IL- 17 were significantly higher in SS patients 
compared to patients with sicca, and ELS+ patients displayed 
higher amounts of the cytokine when compared to ELS− patients 
(Supplementary Figure 1D). This observation suggests that the 
ability of IL- 27 to modulate IL- 17 levels may be impaired in SS 
patients.
To test this hypothesis, cultures of PBMCs from SS patients, 
RA patients, and age- matched healthy donors were treated with 
increasing doses of recombinant human IL- 27 (0, 40, 100, and 200 
ng/ml). Notably, while IL- 27 was able to show dose- dependent inhi-
bition of IL- 17A–producing CD4+ T cells and IL- 17A levels meas-
ured in culture supernatants prepared from healthy donor PBMCs, 
this inhibitory effect was completely lost in SS cultures (Figures 5D–
F). Conversely, in PBMC cultures from SS patients, IL- 27 favored a 
significant increase in the secretion of IFNγ into culture media and 
in the frequency of IFNγ- producing CD4+ T cells, an effect that was 
not observed in healthy donor cells (Figures 5D–F). RA patients 
displayed an intermediate phenotype with a significant reduction in 
the number of IL- 17A–producing CD4+ T cells and a trend toward 
increased IFNγ release (Figures  5D–E), but without a significant 
reduction in IL- 17 release in the supernatant (Figure 5F).
Finally, although previous studies have described IL- 27 as a 
driver of IL- 21 production in T helper cells (41,42), IL- 27 stimu-
lation of CD4+ T cells from SS patients and healthy donors had 
no effect on IL- 21 secretion, nor on the release of the Th17- 
associated cytokine IL- 22, while a modest increase in IL- 10 was 
seen with the highest dose of IL- 27 (Figure 5G). Taken together, 
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these data demonstrate that upon IL- 27 stimulation, CD4+ T cells 
from SS patients display a marked resistance to down- regulation 
of IL- 17A production and an aberrant IFNγ response. This behav-
ior is restricted to SS patients.
DISCUSSION
We have recently shown that, in the context of ELS, when 
functional IL- 27 signaling is missing, lymphoid aggregates with 
some resemblance to ELS developed in the synovium of a model 
of experimental arthritis normally devoid of ELS (40). However, in 
this model, the impact on the local humoral autoimmune response, 
together with the underlying mechanisms governing ELS forma-
tion, remained elusive. Here, in the present inducible model of 
ELS formation, we have shown that the absence of a functional 
IL- 27 signaling results in the heightened expression of key genes 
involved in ELS formation, the development of larger ELS with 
enriched B cell infiltration, and the presence of accelerated and 
enhanced ectopic GC responses.
Consistent with the reported inhibitory role of IL- 27 in Th17 
differentiation (27,29), we observed a remarkable expansion of 
IL- 17–producing CD4+ T cells in the SGs of Il27ra−/− mice, which 
Figure 5. CD4+ T cells from Sjögren’s syndrome (SS) patients display dysfunctional interleukin- 17 (IL- 17) and interferon- γ (IFNγ) responses 
to IL- 27. A, Median fluorescence intensity (MFI) quantification for IL- 27 receptor α (IL- 27Rα) on peripheral blood mononuclear cells from SS 
patients (n = 7) and healthy donors (HDs) (n = 5). B, Representative flow cytometry histograms showing fluorescence intensities for pSTAT1 and 
pSTAT3 in unstimulated and IL- 27–stimulated cells from SS patients and healthy donors. C, MFI for pSTAT1 and pSTAT3 in IL- 27–stimulated 
CD4+ cells, CD8+ cells, and CD20+ cells from SS patients (n = 6) and healthy donors (n = 5). The pSTAT MFI was normalized to that of 
unstimulated cells. D, Representative dot plots for IL- 17A– and IFNγ- producing CD4+ T cells in peripheral blood mononuclear cells from 
SS patients, rheumatoid arthritis (RA) patients, and healthy donors, cultured for 3 days with indicated doses of recombinant IL- 27. Numbers 
indicate gated population as a percentage of total CD4+ T cells. E, Cytokine- producing CD4+ T cells (SS n = 8, RA n = 7, healthy donors 
n = 10). F and G, Levels of IL- 17A, IFNγ, IL- 21, IL- 10, and IL- 22 in cell culture supernatant (SS n = 8, RA n = 6, healthy donors n = 10). In A 
and C, data are shown as box plots. Each box represents the 25th to 75th percentiles. Lines inside the boxes represent the median. Lines 
outside the boxes represent the minimum and maximum values. Symbols represent individual subjects. P values (all not significant [NS]) were 
determined by Mann- Whitney U test. In E–G, symbols represent individual samples; bars show the mean ± SEM. * = P < 0.05, ** = P < 0.01, 
**** = P  < 0.0001, by Friedman’s test with Dunn’s correction for multiple comparisons.
LUCCHESI ET AL 1568       |
was accompanied by a reduction in the local Th1 response. 
Furthermore, an increase in SG- infiltrating FoxP3+ CD4+ T cells 
was also observed in the absence of IL- 27 signaling, which is in 
keeping with the ability of this cytokine to inhibit inducible Treg 
cell differentiation (28). We speculated that the dysregulated for-
mation of ELS in Il27ra−/− mice was due to a loss of an inhibitory 
IL- 27 signal on Th17 differentiation. Treatment of Il27ra−/− mice 
with an anti–IL- 17A antibody during adenovirus infection almost 
completely reversed the excessive GC responses seen in the 
SGs and restored the cellular composition of the ELS, with a 
significant reduction in B cell involvement and CD21+ FDC net-
works, thereby confirming our hypothesis. Notably, preventive 
IL- 17A blockade did not completely inhibit the development of 
ELS in Il27ra−/− mice, suggesting a role for the IL- 27/Th17 effec-
tor response in controlling the propagation rather than the for-
mation of ELS in our model.
While the role of IL- 17A in autoimmunity is well established, 
the relationship between IL- 27, clinical disease progression, 
and Th17- mediated diseases in humans remains ill- defined. 
In the present study, we not only observed higher local and 
systemic levels of IL- 27 in SS patients compared to patients 
with sicca symptoms, but for the first time we showed that in 
SS SGs, the IL- 27p28 protein signal prevalently colocalized 
with DC- LAMP+ mature dendritic cells (but not CD68+ mac-
rophages), which were heavily enriched within the T cell–rich 
areas of the lymphoid aggregates. Similarly, high expression 
of Il27 mRNA was observed in CD11b+ myeloid cells isolated 
from murine SG, synchronous to the infiltration of CD4+ T cells 
in our model. These data suggest that activated dendritic cells 
are a key source of IL- 27 in both mouse and human pathol-
ogy and primarily exert their function by shaping the CD4+ T 
cell response. In our murine model, at later stages of ELS for-
mation, T cells became the prominent producers of IL- 27p28. 
While this is consistent with other recent observations in mice 
(43), we could not confirm IL- 27 production in T cells from the 
SGs of ELS+ SS patients. This suggests that IL- 27–producing 
T cells may be important for the resolution phase of ELS but 
are absent in the persistent inflammation observed in patients 
with SS.
Unexpectedly, and opposite to what we previously reported 
in the RA synovium (40), local IL- 27 expression was found to be 
selectively increased in ELS+ SS patients compared to ELS− 
patients. Notably, CD4+ T cells from patients with SS were 
resistant to the immunoregulatory effects of IL- 27. Upon incuba-
tion with IL- 27, we observed a dose- dependent down- regulation 
of IL- 17 production in CD4+ T cells from healthy individuals, 
while SS patients consistently failed to down- modulate IL- 17 
production and instead displayed exaggerated IFNγ secretion. 
These effects were not due to differences in the presence or 
expression levels of the IL- 27R in CD4+ T cells from SS patients, 
or due to obvious defects in the activation of signaling path-
ways immediately downstream of IL- 27. Thus, in SS patients, 
despite an increased expression of IL- 27 during active disease, 
impaired IL- 27 responsiveness leading to an aberrant control of 
IL- 17 and an excessive IFNγ response may contribute to the 
higher degree of SG immunopathology and ELS development 
observed. Consistent with this hypothesis, Th17 overactivation 
has been associated with the early phases of SG inflammation 
and the formation of ectopic GCs (44), while hyperactivation of 
type II IFN has been advocated as a biomarker of lymphoma 
development in SS (45).
While our model displays several clinical features of 
human SS, the lack of sustained chronicity does not allow for 
an evaluation of the long- term consequences of the aberrant 
ectopic GC response. When we extended our observations 
to patients with SS, we unraveled the existence of profoundly 
altered responsiveness to IL- 27 in CD4+ T cells. These studies 
were limited to in vitro approaches that need to be extended 
in order to pinpoint underlying mechanisms responsible for the 
defective IL- 27 immunoregulatory checkpoint observed. Over-
all, our findings establish IL- 27 as a key suppressor of ectopic 
GC development and suggest that reestablishing the functional 
immunomodulation of the IL- 27/Th17 axis could have thera-
peutic potential in controlling ELS+ autoantibody- mediated dis-
eases such as SS.
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Clinical Images: Unilateral Hippocratic fingers and macaroni sign
The patient, a 17- year- old girl, presented to the emergency department with a 2- week history of pain in her left arm and swelling of the 
fingers on her left hand. Her history was otherwise unremarkable. Notably, there were no symptoms of systemic inflammation (night 
sweats, fever, or weight loss). Clinical examination of the left arm revealed absence of pulses. Blood pressure was low (systolic 50 mm Hg) 
when measured on the left arm and elevated (170/100 mm Hg) when measured on the right arm. Physical examination revealed finger 
clubbing (Hippocratic fingers) only on the left hand. The C- reactive protein level was mildly elevated (1.8 mg/dl [normal <0.5]). Color duplex 
sonography showed filiform long- segment stenosis in the left common carotid artery (CCA) with marked concentric intimal thickening 
(arrow). This sonographic feature, known as macaroni sign, confirmed the diagnosis of Takayasu arteritis (TAK). Ultrasound and magnetic 
resonance angiography revealed an occlusion of the left subclavian and axillary artery (asterisk) as an underlying cause of finger clubbing 
on the left hand. Further imaging also revealed significant bilateral renal artery stenosis causing renovascular hypertension. Immunosup-
pressive and antihypertensive treatment was initiated. Subsequently, renal artery stenosis was treated with stent angioplasty. Bilateral club-
bing can be seen in patients with severe cardiopulmonary disease, classically in patients with congenital cyanotic heart disease. Unilateral 
clubbing is a very rare presentation of TAK, resulting from severe chronic upper limb ischemia (1–3).
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